Advertisement
News
Advertisement

Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary

Fri, 09/30/2011 - 1:33am
Bio-Medicine.Org

SOMERSET, N.J., Sept. 29, 2011 /PRNewswire/ -- Terumo Americas Holdings, Inc., a U.S. subsidiary of Terumo Corporation, today celebrates the 90th anniversary of Terumo Corporation's founding in 1921.  Terumo Corporation is one of the world's leading medical device manufacturers with $4 billion in annual sales and operations in more than 160 countries.

In August, Forbes magazine ranked Terumo Corporation 14th of the top 100 global companies on its "World's Most Innovative Companies" list.  According to Forbes, the rankings were based on findings from an eight year study led by a team of independent industry researchers who assessed each company an "innovation premium," a measure of investor expectation for future innovation such as new product development, services and market development.

"For 90 years, medical professionals have trusted Terumo Corporation, because our deep understanding of their practical, clinical, and economic needs enables us to implement insightful, 'people-friendly' solutions that contribute to better patient outcomes," said Kazuaki Kitabatake, President & CEO, Terumo Americas Holding, Inc. "We are thankful to our customers and Associates worldwide who are the driving force behind Terumo Corporation's strong, long-term stability and evolution as a leader in global healthcare."

Originally founded in Japan by several medical scientists intent on manufacturing the most reliable clinical thermometers, Terumo Corporation has evolved into a global leader in the development, manufacture, and distribution of world-class medical devices in high-growth therapeutic areas of cardiovascular medicine such as cardiothoracic surgery, left-ventricular assist systems for end-stage heart failure, minimally invasive coronary and endovascular interventions, and neuro-interventional technologies for cerebral aneurysms.

In 2011, Terumo strengthened its global portfolio with strategic acquisitions of Caridia

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading